Raymond James & Associates Purchases 1,313 Shares of The Chemours Company (NYSE:CC)

Raymond James & Associates grew its position in shares of The Chemours Company (NYSE:CCGet Rating) by 1.3% in the 3rd quarter, HoldingsChannel reports. The firm owned 102,638 shares of the specialty chemicals company’s stock after acquiring an additional 1,313 shares during the quarter. Raymond James & Associates’ holdings in Chemours were worth $2,530,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in the company. CNB Bank purchased a new position in shares of Chemours during the 2nd quarter worth approximately $25,000. Asset Management One Co. Ltd. bought a new position in shares of Chemours during the 2nd quarter valued at $25,000. Trust Co. of Vermont purchased a new position in Chemours during the second quarter valued at $35,000. Ellevest Inc. lifted its position in Chemours by 34,325.0% during the second quarter. Ellevest Inc. now owns 1,377 shares of the specialty chemicals company’s stock valued at $44,000 after purchasing an additional 1,373 shares in the last quarter. Finally, GPS Wealth Strategies Group LLC lifted its position in Chemours by 82.9% during the second quarter. GPS Wealth Strategies Group LLC now owns 1,655 shares of the specialty chemicals company’s stock valued at $53,000 after purchasing an additional 750 shares in the last quarter. Institutional investors own 71.89% of the company’s stock.

Analyst Ratings Changes

Several equities analysts recently weighed in on CC shares. Argus downgraded Chemours from a “buy” rating to a “hold” rating in a research report on Wednesday, October 5th. The Goldman Sachs Group began coverage on Chemours in a report on Thursday, October 13th. They set a “neutral” rating and a $30.00 price target on the stock. Citigroup raised their price target on Chemours from $30.00 to $33.00 and gave the company a “neutral” rating in a report on Thursday, December 15th. StockNews.com raised Chemours from a “hold” rating to a “buy” rating in a report on Saturday, January 14th. Finally, Credit Suisse Group began coverage on Chemours in a report on Tuesday, November 1st. They set an “underperform” rating and a $24.00 price target on the stock. One equities research analyst has rated the stock with a sell rating, eight have given a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $32.90.

Chemours Trading Up 3.4 %

Shares of CC stock opened at $33.72 on Friday. The stock has a market capitalization of $5.09 billion, a price-to-earnings ratio of 6.01, a price-to-earnings-growth ratio of 0.67 and a beta of 1.84. The Chemours Company has a 12-month low of $22.56 and a 12-month high of $44.95. The company has a current ratio of 1.82, a quick ratio of 1.14 and a debt-to-equity ratio of 2.73. The stock’s 50-day moving average price is $31.67 and its 200-day moving average price is $31.63.

Chemours (NYSE:CCGet Rating) last released its quarterly earnings results on Tuesday, October 25th. The specialty chemicals company reported $1.24 EPS for the quarter, topping the consensus estimate of $1.16 by $0.08. The company had revenue of $1.80 billion during the quarter, compared to analyst estimates of $1.67 billion. Chemours had a return on equity of 73.45% and a net margin of 12.91%. The firm’s revenue was up 7.1% on a year-over-year basis. During the same quarter last year, the business posted $1.27 earnings per share. Equities research analysts predict that The Chemours Company will post 4.74 EPS for the current fiscal year.

Chemours Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, December 15th. Investors of record on Tuesday, November 15th were given a $0.25 dividend. The ex-dividend date was Monday, November 14th. This represents a $1.00 annualized dividend and a yield of 2.97%. Chemours’s dividend payout ratio is currently 17.83%.

Chemours Profile

(Get Rating)

The Chemours Co is a holding company, which engages in the provision of performance chemicals. The firm delivers solutions, which include a range of industrial and chemical products for markets including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and consumer electronics, and general industrial.

See Also

Want to see what other hedge funds are holding CC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Chemours Company (NYSE:CCGet Rating).

Institutional Ownership by Quarter for Chemours (NYSE:CC)

Receive News & Ratings for Chemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemours and related companies with MarketBeat.com's FREE daily email newsletter.